Amicus Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.

About FOLD

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases.

CEO

Bradley Lewis Campbell

CEOBradley Lewis Campbell

Employees

517

Employees517

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2002

Founded2002

Employees

517

Employees517

FOLD Key Statistics

Market cap

3.06B

Market cap3.06B

Price-Earnings ratio

-19.98

Price-Earnings ratio-19.98

Dividend yield

—

Dividend yield—

Average volume

2.60M

Average volume2.60M

High today

$10.46

High today$10.46

Low today

$10.29

Low today$10.29

Open price

$10.37

Open price$10.37

Volume

1.08M

Volume1.08M

52 Week high

$14.57

52 Week high$14.57

52 Week low

$9.70

52 Week low$9.70

FOLD News

Yahoo Finance 6d

Will Amicus Therapeutics Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

The market expects Amicus Therapeutics (FOLD) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended...

Yahoo Finance 6d

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024 - Yahoo Finance

Amicus Therapeutics, Inc. PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a con...

Analyst ratings

73%

of 11 ratings

Buy

72.7%

Hold

27.3%

Sell